Happy Head Introduces Novel Liposomal Hair Growth Topical Cream

Image Courtesy Happy Head

LOS ANGELES, August 1, 2023 (VSNewsNetwork.com) - Happy Head, a skincare company, has announced the development of a liposomal topical cream designed to combat hair loss. The innovative formula, the first of its kind, employs a liposomal base to deliver Finasteride and Minoxidil, both FDA-approved hair growth medications, directly to hair follicles.

The goal of the product is to offer a daily-use treatment that outperforms existing options such as gels and sprays. The liposomal delivery method is said to release the medication gradually, with the intention of minimizing systemic absorption and potential side effects.

Dr. Ben Behnam, M.D., FAAD, and co-founder of Happy Head, emphasized the potential benefits of their formula: "Our liposomal formula can potentially reduce the systemic absorption of Finasteride, which may lead to a lower risk of side effects. Moreover, by including Minoxidil in our topical solution, we aim to enhance blood flow to the scalp, which could contribute to improved hair growth."

Hair loss, a condition that affects more than two-thirds of men and over 40% of women in the United States by the age of 35, can cause considerable psychological distress. While various solutions are currently on the market, the introduction of a liposomal topical cream that combines Minoxidil and Finasteride is unique to Happy Head.

Priced at $179 per 30ml bottle, a month's supply of the new topical cream can be delivered directly to customers' homes.

For additional details about this product, visit Happyhead.com.

Source: Happy Head via Newswire